About Us: Larimar Therapeutics Inc. is a publicly held clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Our lead product candidate, Nomlabofusp (CTI-1601), is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich’s ataxia. Friedreich’s ataxia is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. We have assembled an experienced management team, each of whom has over 20 years of pharmaceutical industry experience. Our management team, employees, and consultants have significant expertise in discovery, non-clinical and clinical development, regulatory affairs, manufacturing and CMC. Our company’s strategy is to become a leader in the treatment of rare diseases by leveraging our cell-penetrating technology platform and applying our team’s know-how to the development of Nomlabofusp and our pipeline projects. We are best characterized by entrepreneurial and scientific leadership and a participatory workforce committed to success. If you are searching for a company where urgency, agility, and commitment to science win the day – we welcome you!

Check all associated application documentation thoroughly before clicking on the apply button at the bottom of this description.

Position Summary: Larimar is seeking a CMC Regulatory Affairs Director to provide professional experience and leadership supporting the global CMC regulatory strategy and regulatory activities to bring products in development through global marketing authorization approval and launch. The Regulatory Affairs Director will be a key member of project teams and the role reports to the Regulatory Affairs Senior Director.

Job Duties/Responsibilities: Larimar Team Membership The Director of CMC Regulatory Affairs will be a key member of the regulatory, clinical project, and technical operations (cross-functional) teams who will manage CMC regulatory aspects of projects related to global clinical trials, global health authority interactions and global marketing submissions and approvals. This person will work independently, and as a member of a team. Liaise internally with other members of the Regulatory Affairs department to coordinate the timely submission of CMC amendments, discuss suitable CMC strategies, evaluate global guidances, all to support the development programs of Larimar. Works closely with RA Sr. Director and serve as backup to other global regulatory activities Strategy, Guidance Responsible for defining, developing and executing global CMC regulatory strategies based on knowledge of guidelines with practical experience (previous IND, CTA, NDA, BLA filings) to successfully achieve objectives for complex Larimar projects Provides detailed and forward-looking tactical advice to technical teams and stakeholders to achieve timely and efficient program submissions and approval, while ensuring compliance with applicable global regulatory requirements Evaluates proposed manufacturing and quality changes for impact to current Health Authority Applications (INDs, CTAs) and provides strategic regulatory guidance for optimal implementation of changes. CMC Documentation, Submissions and HA interactions Develops and manages the content plans for global M3 CMC submissions or responses; coordinates document authoring (new or update), document review, and finalization of high-quality, style-guide compliant CMC documents that align with Larimar’s regulatory submission timing and strategy With Larimar organization, manages the CMC portion of Larimar cross-functions team activity in preparation of meetings with global health authorities to define meeting objectives, development of meeting questions, execute the completion of the meeting package content and ultimate receipt of clear, specific and actional HA feedback based on the objectives of each meeting.

PIad1437343330-30134-38807779